¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

2020 Á¦39ȸ ´ëÇÑÁ¤¸ÆÇÐȸ Ãß°èÇмú´ëȸ : 2020-11-08

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
2020 Á¦39ȸ ´ëÇÑÁ¤¸ÆÇÐȸ Ãß°èÇмú´ëȸ : 2020-11-08
±³À°ÀÏÀÚ : 2020-11-08
±³À°Àå¼Ò : ¼­¿ïµå·¡°ï½ÃƼ  
±³À°ÁÖÁ¦ : 2020 Á¦39ȸ ´ëÇÑÁ¤¸ÆÇÐȸ Ãß°èÇмú´ëȸ      
ÁÖÃÖ±â°ü : ´ëÇÑÇ÷°ü¿Ü°úÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : ´ëÇÑÁ¤¸ÆÇÐȸ  
´ã´çÀÚ : ´ëÇÑÁ¤¸ÆÇÐȸ
¿¬¶ôó : 02-3446-9180  
À̸ÞÀÏ : ksp@koreavein.or.kr      
±³À°Á¾·ù : ¿Ü°ú      
Âü¼®¿¹»óÀοø : 200¸í
Èñ¸ÁÆòÁ¡ : 5Á¡  
Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 5 ½Ã°£ 0ºÐ  
¼¼ºÎ¼ö°­·á : 40,000¿ø      
ºñ°í Á¤È¸¿ø: 2¸¸¿ø Àü¹®ÀÇ/ ÀϹÝÀÇ/ °³¿øÀÇ: 4¸¸¿ø ÁÂÀå/¿¬ÀÚ/ Àü°øÀÇ/ºñÀü¹®ÀÇ/ÆгÎ: ¸éÁ¦      
       
±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±âŸ 11¿ù 08ÀÏ  08:30~08:55 Registration  () 
±âŸ 11¿ù 08ÀÏ ±×·£µåº¼·ë 08:55~09:00 Opening Address  À±»ó¼·(´ëÇÑÁ¤¸ÆÇÐȸ ÀÌ»çÀå) 
±³À°½Ã°£ 11¿ù 08ÀÏ ±×·£µåº¼·ë 09:00~09:10 Venous aneurysm, its evaluation and treatment  È²È«ÇÊ(ÀüºÏ´ëº´¿ø) 
±³À°½Ã°£ 11¿ù 08ÀÏ ±×·£µåº¼·ë 09:10~09:20 The latest update on history of iliac stenting  ÃÖÂùÁß(Ãæ³²´ëº´¿ø) 
±³À°½Ã°£ 11¿ù 08ÀÏ ±×·£µåº¼·ë 09:20~09:30 Diagnostic modalities of pelvic congestion syndrome  ±è°Ç¿ì(¹ÎÆ®º´¿ø) 
±³À°½Ã°£ 11¿ù 08ÀÏ ±×·£µåº¼·ë 09:30~09:40 The latest update on history of foam therapy  À̽Âö(Æí¾ÈÇÏÁöÈäºÎ¿Ü°ú) 
Åä·Ð 11¿ù 08ÀÏ ±×·£µåº¼·ë 09:40~09:50 Discussion  À̽Âö(Æí¾ÈÇÏÁöÈäºÎ¿Ü°ú) 
È޽Ġ11¿ù 08ÀÏ ±×·£µåº¼·ë 09:50~10:10 Coffee Break  () 
±³À°½Ã°£ 11¿ù 08ÀÏ ±×·£µåº¼·ë 10:10~10:20 Neurovascular structures at risk with the operation for varicose veins  ±èÇâ°æ(¼­¿ï¾Æ»êº´¿ø) 
±³À°½Ã°£ 11¿ù 08ÀÏ ±×·£µåº¼·ë 10:20~10:30 Recorded live + Q&A  ±èÇâ°æ(¼­¿ï¾Æ»êº´¿ø) 
±³À°½Ã°£ 11¿ù 08ÀÏ ±×·£µåº¼·ë 10:30~10:40 Lower extremity venous reflux; Truncal vein  ¹é°­¼®(¼­¿ïÀÇ·á¿ø) 
±³À°½Ã°£ 11¿ù 08ÀÏ ±×·£µåº¼·ë 10:40~10:50 Recorded live + Q&A  ¹é°­¼®(¼­¿ïÀÇ·á¿ø) 
±³À°½Ã°£ 11¿ù 08ÀÏ ±×·£µåº¼·ë 10:50~11:00 Lower extremity venous reflux; Perforator vein  Á¶ÁøÇö(°­µ¿°æÈñ´ëº´¿ø) 
±³À°½Ã°£ 11¿ù 08ÀÏ ±×·£µåº¼·ë 11:00~11:10 Recorded live + Q&A  Á¶ÁøÇö(°­µ¿°æÈñ´ëº´¿ø) 
±³À°½Ã°£ 11¿ù 08ÀÏ ±×·£µåº¼·ë 11:10~12:00 Free Papers  È«±âÇ¥(±¹¹Î°Ç°­º¸Çè Àϻ꺴¿ø) 
±³À°½Ã°£ 11¿ù 08ÀÏ ±×·£µåº¼·ë 12:10~12:30 Which drug is the real MPFF?  ±è¼ÛÀÌ(¼¼Á¾Ãæ³²´ëº´¿ø) 
±âŸ 11¿ù 08ÀÏ ±×·£µåº¼·ë 12:50~13:10 ÃÑȸ  () 
±âŸ 11¿ù 08ÀÏ ±×·£µåº¼·ë 13:10~13:30 ¿¬±¸ºñ °¨»çÆÐ ÁõÁ¤ ¹× »çÁø ÃÔ¿µ  () 
±³À°½Ã°£ 11¿ù 08ÀÏ ±×·£µåº¼·ë 13:50~14:00 Postprocedural evaluations of radiofrequency ablation(RFA)  ±èµ¿Çõ(¼ö¿øǪ¸¥¸Æ¿Ü°ú) 
±³À°½Ã°£ 11¿ù 08ÀÏ ±×·£µåº¼·ë 14:00~14:10 Recorded live + Q&A  ±èµ¿Çõ(¼ö¿øǪ¸¥¸Æ¿Ü°ú) 
±³À°½Ã°£ 11¿ù 08ÀÏ ±×·£µåº¼·ë 14:10~14:20 Postprocedural evaluations of endovenous laser ablation(EVLA)  Á¤¿µ±Õ(±¸¹Ì¼öÈäºÎ¿Ü°ú) 
±³À°½Ã°£ 11¿ù 08ÀÏ ±×·£µåº¼·ë 14:20~14:30 Recorded live + Q&A  Á¤¿µ±Õ(±¸¹Ì¼öÈäºÎ¿Ü°ú) 
±³À°½Ã°£ 11¿ù 08ÀÏ ±×·£µåº¼·ë 14:30~14:40 Paget-Schroetter syndrome: what is the best management?  ¾ç½Å¼®(»ï¼º¼­¿ïº´¿ø) 
±³À°½Ã°£ 11¿ù 08ÀÏ ±×·£µåº¼·ë 14:40~14:50 anticonagulation therapy after acute DVT  ÇѾƶ÷(¼­¿ï´ëº´¿ø) 
±³À°½Ã°£ 11¿ù 08ÀÏ ±×·£µåº¼·ë 14:50~15:00 Difficult retrieval of IVC filter: Tips and Tricks  ÀÓ³²¿­(±¤Á̷ֹ¡ÀÇ¿ø) 
±³À°½Ã°£ 11¿ù 08ÀÏ ±×·£µåº¼·ë 15:00~15:10 Role of major RCTs: CAVENT, ATTRACT & DUTCH CAVA  ±è¾ç±â(¼øõÇâ´ë ¼­¿ïº´¿ø) 
È޽Ġ11¿ù 08ÀÏ ±×·£µåº¼·ë 15:10~15:20 Coffee Break  () 
±³À°½Ã°£ 11¿ù 08ÀÏ ±×·£µåº¼·ë 15:20~15:30 Postprocedural evaluations of VenaSeal¢â Closure System  ¹ÚÀμö(ÂüÇÏÁö¿Ü°ú) 
±³À°½Ã°£ 11¿ù 08ÀÏ ±×·£µåº¼·ë 15:30~15:40 Recorded live + Q&A  ¹ÚÀμö(ÂüÇÏÁö¿Ü°ú) 
±³À°½Ã°£ 11¿ù 08ÀÏ ±×·£µåº¼·ë 15:40~15:50 Postprocedural evaluations of ClariVein¢ç  ÀüÈñÀç(ÀüÈñÀçÈäºÎ¿Ü°ú) 
±³À°½Ã°£ 11¿ù 08ÀÏ ±×·£µåº¼·ë 15:50~16:00 Recorded live + Q&A  ÀüÈñÀç(ÀüÈñÀçÈäºÎ¿Ü°ú) 
±âŸ 11¿ù 08ÀÏ ±×·£µåº¼·ë 16:00~16:20 Closing Address (Çмú»ó ¹× ¿ì¼ö³í¹® Æ÷»ó)  À±»ó¼·(´ëÇÑÁ¤¸ÆÇÐȸ ÀÌ»çÀå) 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" 2020 Á¦39ȸ ´ëÇÑÁ¤¸ÆÇÐȸ Ãß°èÇмú´ëȸ : 2020-11-08""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û (¿Â¶óÀÎ)Á¦8ȸ ´ëÇѼҾÆÀ̺ñÀÎÈÄ°úÇÐȸ ±³À°°­Á : 2020-11-08
´ÙÀ½±Û (¿Â¶óÀÎ) 2020³â ´ëÇÑ¿Ü°úÀÇ»çȸ Ã߰迬¼ö°­Á : 2020-11-08
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
660 Àü³² 2018³â ´ëÇѼÒÈ­±â³»½Ã°æÇÐȸ ±¤ÁÖÀü³²Áöȸ Áý´ãȸ : 2018-10-12 0 763 2018-08-29
659 ¼­¿ï ¼­¿ï´ëÇб³º´¿ø ¾È°ú ±Ý¿ä¼¼¹Ì³ª(¼±Ãµ°¢¸·È¥Å¹) : 2018-10-12 0 404 2018-08-29
658 ¼­¿ï »ï¼º¼­¿ïº´¿ø 2018 »ï¼º ¾È°ú ±Ý¿äÁý´ãȸ(¸Á¸·ÁúȯÀÇ À¯ÀüÀÚ °Ë»ç) : 2018-10-12 0 961 2018-08-29
657 ¼­¿ï 2018 Á¾¾ç¸é¿ª´ÙÇÐÁ¦¿¬±¸È¸ Ãß°è½ÉÆ÷Áö¾ö (MSIO Fall Conference) : 2018-10-12 0 466 2018-08-29
656 °­¿ø 2018³â ´ëÇѼÒÈ­±â³»½Ã°æÇÐȸ °­¿øÁöȸ Áý´ãȸ : 2018-10-12 0 491 2018-08-29
655 °æ±â ±¹¸³¾Ï¼¾ÅÍ Á¦4Â÷ ÀÇ»ý¸í°úÇÐÆ÷·³ : 2018-10-12 0 366 2018-08-29
654 ¼­¿ï ¼¼ºê¶õ½ºº´¿ø ¾È°ú ±Ý¿äÁý´ãȸ : 2018-10-12 0 371 2018-08-29
653 ¼­¿ï °í·Á´ëÇб³±¸·Îº´¿ø 1) °¨¿° ÇǺÎÁúȯ 2) ÇǺΠºÎ¼Ó±â Áúȯ : 2018-10-11 0 555 2018-08-29
652 ¼­¿ï [Á¦27±â ÀÇ·áÁ¤Ã¥ÃÖ°íÀ§°úÁ¤] °Ç°­º¸Çè ±Þ¿©±âÁØ°ú ½É»ç : 2018-10-11 0 595 2018-08-29
651 ¼­¿ï 2018³â ½ÅÁ¾ ¹× »ý¹°Å×·¯°¨¿°º´ ´ëÀÀÀü¹®¿ä¿ø ½ÉÈ­±³À°(»çÀüµî·Ï Çʼö) : 2018-10-11 0 409 2018-08-29
650 °æ±â ÇѸ²´ëÇб³¼º½Éº´¿ø ÇÑÀÌȸ(Implant related dental sinusitis) : 2018-10-10 0 527 2018-08-29
649 °æ³² °æ»ó´ëÇб³ ÀÇ°ú´ëÇÐ ¼­ºÎ°æ³² À̺ñÀÎÈÄ°ú Áý´ãȸ : 2018-10-10 0 562 2018-08-29
648 ¼­¿ï Áß¾Ó´ëÇб³º´¿ø À̺ñÀÎÈÄ°ú Áö¿ªÀÇ»ç ¿ù·ÊÁý´ãȸ : 2018-10-10 0 547 2018-08-29
647 Á¦ÁÖ ´ëÇѳúÀüÁõÇÐȸ Á¦6Â÷ ÄÉÅæ»ý¼º ½ÄÀÌÄ¡·á ±Û·Î¹ú ½ÉÆ÷Áö¾ö (6th Global Symposium on Ketogenic Therapies for Neurological Disorders) : 2018-10-09 0 540 2018-08-29
646 Á¦ÁÖ ´ëÇѳúÀüÁõÇÐȸ Á¦6Â÷ ÄÉÅæ»ý¼º ½ÄÀÌÄ¡·á ±Û·Î¹ú ½ÉÆ÷Áö¾ö (6th Global Symposium on Ketogenic Therapies for Neurological Disorders) : 2018-10-08 0 562 2018-08-29
1361 | 1362 | 1363 | 1364 | 1365 | 1366 | 1367 | 1368 | 1369 | 1370
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷